. "I think the US IPO listing has been on the radar for a very long time, but never seems to have solid steps towards this."
I am wondering about the listing ht. Popular consensus seems to be that the pivotal trial will not commence until next year - 2025. If the company can produce some positive news to the market and move the share price up (probably to around $30) there is the possibility of major shareholders converting their $29 oppies due 15/2/25 to raise a total of approx. $56.6m. Should go a long way towards funding the trial but could be a bit risky to depend on it.
- Forums
- ASX - By Stock
- AVR
- What’s Next?
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

What’s Next?, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
Price($) | Vol. | No. |
---|---|---|
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
6.600 | 320 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online